Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: January 2007
-
By Mark Chael — An intellectual property lawsuit is slated to begin on March 12, 2007, pitting Genzyme Corp. against three executives at a Canadian firm, Cytochroma, which is developing therapies for vitamin D deficiency and chronic kidney disease (CKD). Genzyme alleges that the executives misappropriated trade secrets and other intellectual property prior…
-
By Christopher P. Singer — In a January 30, 2007 notice, the U.S. Patent and Trademark Office announced revised procedures relating to what patent applicants and practitioners must do in response to the dreaded Notice of Omitted Items. This Notice is what every practitioner fears, as it reflects a determination by the Office…
-
By Christopher P. Singer — In a January 24, 2007 press release, EvoGenix Ltd announced that U.S. Patent No. 7,166,697, titled "V-like domain binding molecules" has been granted by the U.S. Patent Office. According to EvoGenix, the patent covers a protein technology termed "Evibodies®," which are similar to antibodies and are useful in…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office today (January 30, 2007) presented a webinar that detailed certain issues relating to document indexing and descriptions of filings submitted with the USPTO via EFS-Web. The seminar provided helpful explanations and tips regarding how to describe submissions properly so that they are…
-
Innogenetics Appeals Its Win over Abbott By Robert Dailey — In two earlier posts (January 8 and January 12), we reported on Innogenetics' $7 million victory after a jury found that Abbott had infringed Innogenetics' patent covering methods for HCV genotyping. The jury also found that Abbott's conduct had been willful. However, in a…
-
By Kevin Noonan — The New York Times continued its recent campaign against patents this week, running an Op-Ed piece by Denise Caruso on gene patenting. Perhaps this attack is rooted in the Times loss before the Supreme Court a few years ago when it tried to usurp copyright from authors for online…
-
By Jason Derry — PharmaLive has reported that Vanderbilt-Ingram Cancer Center and the University of Michigan added their names to the list of members currently involved in Sigma-Aldrich's RNAi Partnership Program. The Program was set up by Sigma-Aldrich to provide members with access to its functional genomics portfolio, which comprises shRNA libraries that…
-
Monday & Tuesday – Biotechnology 2007 (Law Seminars International) – San Francisco, CA Monday & Tuesday – BIO-Asia Partnering Conference (Biotechnology Industry Organization) – Tokyo, Japan February 27-28, 2007 – Patent Portfolio Management (American Conference Institute) – New York, NY March 25-29, 2007 – American Chemical Society National Meeting – Chicago, IL April 16-18, 2007…
-
By Christopher P. Singer — On January 30, 2007 at 1:00pm (EST) the USPTO will provide online training regarding proper document indexing when submitting filings using EFS-Web. Proper indexing of documents is important for minimizing potential errors and delays in the Patent Office's processing of submissions by EFS-Web. Since enrollment for this event…
-
The American Chemical Society is holding its Spring 2007 meeting on March 25-29 in Chicago, Illinois. According to the ACS website, over 12000 attendees are expected. We note that our colleagues Steve Sarussi and Brad Crawford will be giving presentations at the meeting on March 28th during a session entitled: "Ensuring the Effective Patent Protection…
Patent Docs 